F Calvo Selected Research

F Calvo Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 05/2000
3	Breast Neoplasms (Breast Cancer) 06/2010 - 11/2000
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 02/2004
2	Neutropenia 01/2009 - 10/2002
2	Pain (Aches) 05/2008 - 12/2002
2	Stomach Neoplasms (Stomach Cancer) 05/2004 - 04/2004
2	Chronic Hepatitis C 12/2002 - 09/2002
1	Microsatellite Instability 01/2020
1	Ketosis 09/2015
1	Glucosephosphate Dehydrogenase Deficiency 09/2015
1	Medulloblastoma 01/2014
1	Rectal Neoplasms (Rectal Cancer) 04/2013
1	Stomatitis 01/2009
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2009
1	Thrombocytopenia (Thrombopenia) 01/2009
1	Hemangiosarcoma (Angiosarcoma) 01/2009
1	Asthenia 01/2009
1	Colonic Neoplasms (Colon Cancer) 12/2008
1	Hemochromatosis (Bronze Diabetes) 11/2008
1	Neoplasm Metastasis (Metastasis) 05/2008
1	Cross Infection (Nosocomial Infection) 10/2006
1	Infections 10/2006
1	Abdominal Pain (Pain, Abdominal) 10/2004
1	Crohn Disease (Crohn's Disease) 10/2004
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 03/2004
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2004
1	Bacteremia 09/2003
1	Psoas Abscess 09/2003
1	Edema (Dropsy) 12/2002
1	Hemolysis 12/2002
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 10/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2002
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2002
1	Squamous Cell Carcinoma of Head and Neck 10/2002
1	Febrile Neutropenia 10/2002
1	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2001

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2006
2	ErbB Receptors (EGF Receptor)IBA 06/2010 - 08/2001
2	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2007 - 09/2001
2	InterferonsIBA 12/2002 - 09/2002
2	Ribavirin (Virazole)FDA LinkGeneric 12/2002 - 09/2002
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	larotrectinibIBA 01/2020
1	TropomyosinIBA 01/2020
1	entrectinibIBA 01/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 09/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2013
1	LigandsIBA 06/2010
1	Complementary DNA (cDNA)IBA 06/2010
1	taxaneIBA 01/2009
1	Everolimus FDA Link 01/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2009
1	EnzymesIBA 01/2009
1	Cytotoxins (Cytolysins)IBA 12/2008
1	Antineoplastic Agents (Antineoplastics)IBA 12/2008
1	3-ingenyl angelateIBA 12/2008
1	Protein Isoforms (Isoforms)IBA 12/2008
1	ingenolIBA 12/2008
1	tetrapeptide carbamateIBA 11/2008
1	HepcidinsIBA 11/2008
1	FurinIBA 11/2008
1	Analgesics (Analgesic Drugs)IBA 05/2008
1	Zoledronic Acid (Zometa)FDA Link 05/2008
1	NucleosidesIBA 09/2007
1	sapacitabineIBA 09/2007
1	Gemcitabine FDA Link 09/2007
1	Meropenem (Merrem)FDA LinkGeneric 10/2006
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2006
1	Imipenem FDA Link 10/2006
1	Amikacin (A.M.K)FDA LinkGeneric 10/2006
1	Inosine Monophosphate (IMP)IBA 10/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2004
1	Fibrinogen (Factor I)FDA Link 10/2004
1	C-Reactive ProteinIBA 10/2004
1	Capsules (Microcapsules)IBA 03/2004
1	oxidized low density lipoproteinIBA 02/2004
1	Apolipoproteins AIBA 02/2004
1	AntibodiesIBA 12/2002
1	CytokinesIBA 12/2002
1	Imatinib Mesylate (Gleevec)FDA Link 10/2002
1	Fluorouracil (Carac)FDA LinkGeneric 10/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2001

Therapy/Procedure

4	Therapeutics 11/2016 - 10/2001
2	Radiotherapy 05/2008 - 03/2006
2	Gastrectomy 05/2004 - 04/2004
2	Catheters 09/2003 - 10/2002
1	Immunotherapy 01/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2014
1	Craniospinal Irradiation 01/2014
1	Laparotomy 04/2004
1	Surgical Instruments (Clip) 03/2004
1	Conversion to Open Surgery 03/2004
1	Aftercare (After-Treatment) 12/2002
1	TP protocol 10/2002
1	Induction Chemotherapy 10/2002
1	Retreatment 09/2002